Neurovascular and Immune Mechanisms in AD Pathogenesis
About the Research Project
Program
Award Type
Postdoctoral Fellowship
Award Amount
$200,000
Active Dates
July 01, 2021 - June 30, 2023
Grant ID
A2021019F
Goals
By elucidating the mechanisms of blood clotting factors in immune activation and memory loss, our study will provide the basis for novel strategies for therapeutic intervention in AD.
Summary
This proposal will use a multi-pronged experimental design to examine the cerebrovascular mechanisms regulating neuronal dysfunction in AD. We will use state-of-the-art imaging to study neurons in living mice and with subcellular resolution. We will determine the transcriptional machinery of neurotoxic brain immune cells in the brain of AD mice at the single-cell level.
Unique and Innovative
This project will fill a major knowledge gap, namely the mechanisms that link cerebrovascular damage with pathogenic immune activation and neuronal dysfunction in AD. Emerging evidence shows that cerebrovascular pathology, BBB disruption, and fibrinogen deposition in AD brains is not merely a consequence of disease but plays a causal role in inflammation, oxidative stress and neurodegeneration. This proposal will discover novel neurotoxic mechanisms and therapeutic targets for AD at the neurovascular interface.
Foreseeable Benefits
This proposal will revolutionize our understanding of the cellular and molecular triggers of neurodegeneration in AD. By elucidating the molecular mechanism of blood clotting factors in brain immune activation and memory loss, our study will provide the basis for novel strategies for therapeutic intervention to protect from cerebrovascular dysfunction in AD.
Related Grants
Alzheimer's Disease Research
Targeting Proinflammatory Molecules Using a Chimeric Receptor to Reduce Inflammation and Tauopathy
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Gilbert Gallardo, PhD
Current Organization
Washington University in St. Louis
Targeting Proinflammatory Molecules Using a Chimeric Receptor to Reduce Inflammation and Tauopathy
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Gilbert Gallardo, PhD
Current Organization
Washington University in St. Louis
Alzheimer's Disease Research
Does Fructose Contribute to Neurodegeneration and Alzheimer's Disease Development?
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Justin Perry, PhD
Current Organization
Memorial Sloan Kettering Cancer Center
Does Fructose Contribute to Neurodegeneration and Alzheimer's Disease Development?
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Justin Perry, PhD
Current Organization
Memorial Sloan Kettering Cancer Center
Alzheimer's Disease Research
Investigating Autoimmune Contributions to Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Jennifer Yokoyama, PhD
Current Organization
University of California, San Francisco
Investigating Autoimmune Contributions to Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Jennifer Yokoyama, PhD
Current Organization
University of California, San Francisco